The escalating threat of antimicrobial resistance (AMR) poses a significant challenge to the effective treatment of necrotizing fasciitis. The disease is often caused by bacteria like Staphylococcus aureus and Streptococcus pyogenes, and the rise of drug-resistant strains, such as Methicillin-resistant Staphylococcus aureus (MRSA), complicates treatment protocols and drives the need for...